Cor.Sync is biotetchnology company that offers ischemic cardiovascular disease diagnosis services at the emergency care.
Cor.Sync has raised $165K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2022.
Cor.Sync's investors include DOMO.VC, NTT Data, Fundação de Amparo à Pesquisa do Estado de SP, FINEP, Uniangels.
Cor.Sync is headquartered in São Paulo, Brazil.
Cor.Sync is biotetchnology company that offers ischemic cardiovascular disease diagnosis services at the emergency care.
Cor.Sync is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cor.Sync — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/corsync. Accessed September 30, 2026.
VCBacked. (2022). Cor.Sync — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/corsync
{{cite web |title=Cor.Sync — Funding & Investors |url=https://www.vcbacked.co/company/corsync |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated